Department of Orthopaedics, The Third Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325200, China.
Department of Industrial and Systems Engineering, Virginia Tech, Blacksburg, VA 24061, USA.
Acta Biomater. 2019 Jan 15;84:16-33. doi: 10.1016/j.actbio.2018.11.039. Epub 2018 Nov 24.
Critical-sized bone defect repair remains a substantial challenge in clinical settings and requires bone grafts or bone substitute materials. However, existing biomaterials often do not meet the clinical requirements of structural support, osteoinductive property, and controllable biodegradability. To treat large-scale bone defects, the development of three-dimensional (3D) porous scaffolds has received considerable focus within bone engineering. A variety of biomaterials and manufacturing methods, including 3D printing, have emerged to fabricate patient-specific bioactive scaffolds that possess controlled micro-architectures for bridging bone defects in complex configurations. During the last decade, with the development of the 3D printing industry, a large number of tissue-engineered scaffolds have been created for preclinical and clinical applications using novel materials and innovative technologies. Thus, this review provides a brief overview of current progress in existing biomaterials and tissue engineering scaffolds prepared by 3D printing technologies, with an emphasis on the material selection, scaffold design optimization, and their preclinical and clinical applications in the repair of critical-sized bone defects. Furthermore, it will elaborate on the current limitations and potential future prospects of 3D printing technology. STATEMENT OF SIGNIFICANCE: 3D printing has emerged as a critical fabrication process for bone engineering due to its ability to control bulk geometry and internal structure of tissue scaffolds. The advancement of bioprinting methods and compatible ink materials for bone engineering have been a major focus to develop optimal 3D scaffolds for bone defect repair. Achieving a successful balance of cellular function, cellular viability, and mechanical integrity under load-bearing conditions is critical. Hybridization of natural and synthetic polymer-based materials is a promising approach to create novel tissue engineered scaffolds that combines the advantages of both materials and meets various requirements, including biological activity, mechanical strength, easy fabrication and controllable degradation. 3D printing is linked to the future of bone grafts to create on-demand patient-specific scaffolds.
骨缺损的修复仍然是临床治疗中的一个重大挑战,需要进行骨移植或使用骨替代材料。然而,现有的生物材料往往无法满足结构支撑、成骨诱导特性和可控制的生物降解性等临床要求。为了治疗大规模的骨缺损,骨工程领域已经对三维(3D)多孔支架的开发给予了相当大的关注。出现了各种生物材料和制造方法,包括 3D 打印,用于制造具有可控微观结构的个性化生物活性支架,以桥接复杂结构的骨缺损。在过去的十年中,随着 3D 打印行业的发展,使用新型材料和创新技术,已经为临床前和临床应用创建了大量组织工程支架。因此,本文简要综述了现有的生物材料和通过 3D 打印技术制备的组织工程支架的最新进展,重点介绍了材料选择、支架设计优化以及它们在修复大尺寸骨缺损方面的临床前和临床应用。此外,本文还阐述了 3D 打印技术的当前局限性和潜在的未来前景。
意义陈述:3D 打印技术因其能够控制组织支架的整体几何形状和内部结构,已成为骨工程的关键制造工艺。骨工程中生物打印方法和兼容的墨水材料的进步一直是开发用于骨缺损修复的最佳 3D 支架的主要关注点。在承载条件下实现细胞功能、细胞活力和机械完整性的成功平衡至关重要。天然和合成聚合物基材料的杂交是一种很有前途的方法,可以创建具有新颖组织工程支架,结合两种材料的优点,并满足各种要求,包括生物活性、机械强度、易于制造和可控降解。3D 打印与骨移植物的未来息息相关,可用于创建按需的个性化患者特定支架。
Acta Biomater. 2018-11-24
Curr Drug Deliv. 2021
J Biomed Mater Res B Appl Biomater. 2019-3-8
Mater Today Bio. 2025-8-20
Bioengineering (Basel). 2025-8-11
Comput Struct Biotechnol J. 2025-6-6